Article info

Download PDFPDF

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis
  1. Correspondence to:
 Dr Dean M Wingerchuk
 Mayo Clinic, Scottsdale, Arizona, USA; wingerchuk.deanmayo.edu
View Full Text

Citation

Wingerchuk DM, Lesaux J, Rice GPA, et al
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis

Publication history

  • Received October 17, 2004
  • Accepted January 4, 2005
  • Revised November 29, 2004
  • First published August 16, 2005.
Online issue publication 
August 16, 2005

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.